The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Syzygium jambolanum
Syzygium Cumini Seed · SYZYGIUM CUMINI SEED 6 [hp_C]/6[hp_C] · Pellet · Oral · Boiron
NDC 00220-7841-41 · 6 [hp_C] in 1 TUBE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Syzygium Cumini Seed (Pellet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Boiron | SYZYGIUM CUMINI SEED 30 [hp_C]/30[hp_C] | Jul 15, 2026 | Sep 2, 2026 |
| Boiron | SYZYGIUM CUMINI SEED 6 [hp_C]/6[hp_C] | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Syzygium jambolanum — NDC 00220-7841-41," retrieved September 3, 2026, https://drugdashboards.com/drug/00220784141.
Free to cite with attribution — see how the data is put together.